B. SCHARLING

Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler®

Tal Engel, J. H. Heinig, H.‐J. Malling et al. · Allergy · 1989 · 100 citations

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

Tanja Busk Bidstrup, Nicolaj M. Stilling, Per Damkier et al. · European Journal of Clinical Pharmacology · 2004 · 83 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9

Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes.

Tal Engel, B. SCHARLING, B Skovsted et al. · British Journal of Clinical Pharmacology · 1992 · 57 citations · Full text

Asthma, Acute Lung Injury, Plasma Concentrations +15

Evaluation of the safety and pharmacokinetics of a fast‐acting recombinant FVIIa analogue, NN1731, in healthy male subjects

Judi Møss, B. SCHARLING, Mirella Ezban et al. · Journal of Thrombosis and Haemostasis · 2008 · 52 citations · Full text

Medicine, Clinical Pharmacology, Pharmacotherapy +3

A randomized, double‐blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25°C stable formulation

Britta Væver Bysted, B. SCHARLING, Tom Møller et al. · Haemophilia · 2007 · 41 citations